Senior insider sale
Chief Commercial Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$116.8K
2.50K shares
What this filing means
KALOFONOS ISABEL plans to sell 2.50K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $116.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/5/2026ACC: 0001950047-26-000146
Officer· Chief Commercial Officer
Since Feb 2026
2.50K
Shares to sell
$116.8K
Approx. market value
2.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
1/5/2026
2.50KTotal acquired2.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/5/2026 | Exercise of Stock Options Cash | 2.50K | — |
| Total | 2.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.50K
Market value
$116.8K
1/5/2026
Total
Units
2.50K
Value
$116.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/5/2026 | 2.50K | $116.8K | NASDAQ | Planned |
| Total | 2.50K | $116.8K | ||